|
|
| G
|
Gria1
|
glutamate ionotropic receptor AMPA type subunit 1
|
decreases expression
|
EXP
|
Glutamate decreases expression of Gria1 protein in interneurons, medium spiny neurons
|
RGD |
PMID:12390532 |
RGD:405649864 |
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
multiple interactions increases activity
|
ISO
|
dihydroactinidiolide inhibits the reaction [Glutamic Acid results in increased activity of ACHE protein]
|
CTD |
PMID:33617922 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Acsl4
|
acyl-CoA synthetase long-chain family member 4
|
multiple interactions increases expression
|
ISO
|
gastrodin inhibits the reaction [Glutamic Acid results in increased expression of ACSL4 protein]
|
CTD |
PMID:31698019 |
|
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions increases phosphorylation
|
ISO
|
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein]; 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein]; 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [[JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein]; [3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein; [cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein; [JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein; AM 251 inhibits the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein]; AM 251 inhibits the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein]; AM 251 inhibits the reaction [[JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein]; CNR1 protein affects the reaction [Glutamic Acid results in increased phosphorylation of AKT1 protein]; GRM5 protein affects the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein]; GRM5 protein affects the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein]; GRM5 protein affects the reaction [[JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein]; GRM5 protein affects the reaction [Glutamic Acid results in increased phosphorylation of AKT1 protein]
|
CTD |
PMID:27543109 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
App
|
amyloid beta precursor protein
|
multiple interactions
|
ISO
|
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Glutamic Acid; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Glutamic Acid]
|
CTD |
PMID:39172838 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Arhgdia
|
Rho GDP dissociation inhibitor alpha
|
decreases expression
|
EXP
|
Glutamic Acid results in decreased expression of ARHGDIA mRNA
|
CTD |
PMID:25797319 |
|
NCBI chr10:106,352,858...106,356,347
Ensembl chr10:106,353,491...106,356,347
|
|
| G
|
Atf4
|
activating transcription factor 4
|
increases expression multiple interactions
|
EXP
|
Glutamic Acid results in increased expression of ATF4 protein sinapinic acid inhibits the reaction [Glutamic Acid results in increased expression of ATF4 protein]
|
CTD |
PMID:39615638 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
| G
|
Atf6
|
activating transcription factor 6
|
multiple interactions increases expression
|
EXP
|
shikonin inhibits the reaction [Glutamic Acid results in increased expression of ATF6 protein]
|
CTD |
PMID:35028790 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
ISO EXP
|
dihydroactinidiolide inhibits the reaction [Glutamic Acid results in increased expression of BAX protein] [Enzyme Activators results in increased activity of EIF2AK3 protein] inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of BAX protein]]; Glutamic Acid results in increased expression of and affects the localization of BAX protein; shikonin inhibits the reaction [Glutamic Acid results in increased expression of and affects the localization of BAX protein]; ursodoxicoltaurine inhibits the reaction [Glutamic Acid results in increased expression of BAX protein]
|
CTD |
PMID:33617922 PMID:35028790 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
EXP ISO
|
Glutamic Acid results in decreased expression of BCL2 protein 1,3-benzothiazol-2-yl(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]]; Memantine analog inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]; Memantine inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]; MKC8866 promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]]; shikonin inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]; ursodoxicoltaurine inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]; ursodoxicoltaurine inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]] dihydroactinidiolide inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]
|
CTD |
PMID:32092300 PMID:33617922 PMID:35028790 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
C1qb
|
complement C1q B chain
|
increases expression
|
EXP
|
Glutamic Acid results in increased expression of C1QB mRNA
|
CTD |
PMID:7870303 |
|
NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840
|
|
| G
|
Casp12
|
caspase 12
|
multiple interactions
|
EXP
|
[Enzyme Activators results in increased activity of EIF2AK3 protein] inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased cleavage of CASP12 protein]]; Glutamic Acid results in increased expression of and results in increased cleavage of CASP12 protein; shikonin inhibits the reaction [Glutamic Acid results in increased expression of and results in increased cleavage of CASP12 protein]
|
CTD |
PMID:35028790 |
|
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases activity increases expression increases cleavage
|
ISO EXP
|
Dronabinol inhibits the reaction [Glutamic Acid results in increased activity of CASP3 protein] Glutamic Acid results in increased expression of CASP3 protein [Glutamic Acid co-treated with malic acid co-treated with Ubiquinone] inhibits the reaction [chromium hexavalent ion results in increased activity of CASP3 protein]; [Glutamic Acid co-treated with malic acid] inhibits the reaction [chromium hexavalent ion results in increased activity of CASP3 protein]; dihydroactinidiolide inhibits the reaction [Glutamic Acid results in increased expression of CASP3 protein] schizandrin inhibits the reaction [Glutamic Acid results in increased expression of CASP3 protein]; shikonin inhibits the reaction [Glutamic Acid results in increased expression of CASP3 protein modified form]; sinapinic acid inhibits the reaction [Glutamic Acid results in increased cleavage of CASP3 protein] Glutamic Acid results in increased expression of CASP3 protein; Glutamic Acid results in increased expression of CASP3 protein modified form
|
CTD |
PMID:18490855 PMID:24732427 PMID:27654887 PMID:33617922 PMID:35028790 PMID:39615638 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
increases expression multiple interactions
|
EXP
|
Glutamic Acid results in increased expression of CASP9 protein schizandrin inhibits the reaction [Glutamic Acid results in increased expression of CASP9 protein]
|
CTD |
PMID:18490855 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Clu
|
clusterin
|
increases expression
|
EXP
|
Glutamic Acid results in increased expression of CLU mRNA
|
CTD |
PMID:7870303 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Cnr1
|
cannabinoid receptor 1
|
multiple interactions
|
ISO
|
CNR1 protein affects the reaction [Glutamic Acid results in increased phosphorylation of AKT1 protein]; CNR1 protein affects the reaction [Glutamic Acid results in increased phosphorylation of MAPK1 protein]; CNR1 protein affects the reaction [Glutamic Acid results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:27543109 |
|
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions increases expression
|
EXP
|
[Enzyme Activators results in increased activity of EIF2AK3 protein] inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of DDIT3 protein]]; shikonin inhibits the reaction [Glutamic Acid results in increased expression of DDIT3 protein]; sinapinic acid inhibits the reaction [Glutamic Acid results in increased expression of DDIT3 protein]
|
CTD |
PMID:35028790 PMID:39615638 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
increases phosphorylation multiple interactions
|
EXP
|
Glutamic Acid results in increased phosphorylation of EIF2AK3 protein [Enzyme Activators results in increased activity of EIF2AK3 protein] inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased cleavage of CASP12 protein]]; [Enzyme Activators results in increased activity of EIF2AK3 protein] inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of BAX protein]]; [Enzyme Activators results in increased activity of EIF2AK3 protein] inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of DDIT3 protein]]; GSK2656157 promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2AK3 protein]]; shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2AK3 protein]; ursodoxicoltaurine inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2AK3 protein]; ursodoxicoltaurine promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2AK3 protein]]
|
CTD |
PMID:35028790 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
multiple interactions increases phosphorylation
|
EXP
|
GSK2656157 promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2S1 protein]]; shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2S1 protein]; ursodoxicoltaurine inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2S1 protein]; ursodoxicoltaurine promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2S1 protein]]
|
CTD |
PMID:35028790 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
multiple interactions increases phosphorylation
|
EXP
|
shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of ERN1 protein]
|
CTD |
PMID:35028790 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Gad1
|
glutamate decarboxylase 1
|
multiple interactions
|
ISO
|
[GAD1 protein binds to Pyridoxal Phosphate] which binds to and results in increased metabolism of Glutamic Acid
|
CTD |
PMID:35151785 |
|
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759
|
|
| G
|
Gad2
|
glutamate decarboxylase 2
|
multiple interactions
|
ISO
|
[GAD2 protein binds to Pyridoxal Phosphate] which binds to and results in increased metabolism of Glutamic Acid
|
CTD |
PMID:35151785 |
|
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:89,671,716...89,941,089
|
|
| G
|
Got1l1
|
glutamic-oxaloacetic transaminase 1-like 1
|
affects abundance
|
ISO
|
GOT1L1 protein affects the abundance of Glutamic Acid
|
CTD |
PMID:25287256 |
|
NCBI chr16:71,563,562...71,576,446
Ensembl chr16:71,563,534...71,570,468
|
|
| G
|
Gpx4
|
glutathione peroxidase 4
|
multiple interactions decreases expression
|
ISO
|
gastrodin inhibits the reaction [Glutamic Acid results in decreased expression of GPX4 mRNA]; gastrodin inhibits the reaction [Glutamic Acid results in decreased expression of GPX4 protein] Glutamic Acid results in decreased expression of GPX4 mRNA; Glutamic Acid results in decreased expression of GPX4 protein
|
CTD |
PMID:31698019 |
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
| G
|
Grm5
|
glutamate metabotropic receptor 5
|
affects response to substance multiple interactions
|
ISO
|
GRM5 protein affects the susceptibility to Glutamic Acid GRM5 protein affects the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein]; GRM5 protein affects the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; GRM5 protein affects the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; GRM5 protein affects the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein]; GRM5 protein affects the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; GRM5 protein affects the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; GRM5 protein affects the reaction [[JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of AKT1 protein]; GRM5 protein affects the reaction [[JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; GRM5 protein affects the reaction [[JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; GRM5 protein affects the reaction [Glutamic Acid results in increased phosphorylation of AKT1 protein]; GRM5 protein affects the reaction [Glutamic Acid results in increased phosphorylation of MAPK1 protein]; GRM5 protein affects the reaction [Glutamic Acid results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:27543109 |
|
NCBI chr 1:150,722,711...151,297,585
Ensembl chr 1:150,733,678...151,296,649
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions
|
EXP
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Memantine analog inhibits the reaction [Glutamic Acid results in decreased phosphorylation of and results in increased activity of GSK3B protein]]; Glutamic Acid results in decreased phosphorylation of and results in increased activity of GSK3B protein; Memantine analog inhibits the reaction [Glutamic Acid results in decreased phosphorylation of and results in increased activity of GSK3B protein]
|
CTD |
PMID:32092300 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions decreases expression
|
ISO
|
gastrodin inhibits the reaction [Glutamic Acid results in decreased expression of HMOX1 protein] [dihydroactinidiolide co-treated with Glutamic Acid] results in increased expression of HMOX1 mRNA
|
CTD |
PMID:31698019 PMID:33617922 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hsd17b10
|
hydroxysteroid (17-beta) dehydrogenase 10
|
decreases expression
|
EXP
|
Glutamic Acid results in decreased expression of HSD17B10 mRNA
|
CTD |
PMID:25797319 |
|
NCBI chr X:24,568,551...24,571,012
Ensembl chr X:24,568,551...24,574,681
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression multiple interactions
|
EXP
|
Glutamic Acid results in increased expression of HSPA5 protein sinapinic acid inhibits the reaction [Glutamic Acid results in increased expression of HSPA5 protein]
|
CTD |
PMID:39615638 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions increases expression
|
EXP
|
sinapinic acid inhibits the reaction [Glutamic Acid results in increased expression of IL1B protein]
|
CTD |
PMID:39615638 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Itpr3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
affects metabolic processing
|
ISO
|
ITPR3 mutant form affects the metabolism of Glutamic Acid
|
CTD |
PMID:32853769 |
|
NCBI chr20:5,138,553...5,204,189
Ensembl chr20:5,118,834...5,204,184
|
|
| G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
multiple interactions
|
ISO
|
[TNF protein co-treated with Glutamic Acid] results in increased activity of MAP3K7 protein
|
CTD |
PMID:36912451 |
|
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions increases phosphorylation
|
EXP ISO
|
[bisphenol A co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein; [Dihydrotestosterone co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein; [Estradiol co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein; afimoxifene inhibits the reaction [[bisphenol A co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; bisphenol A inhibits the reaction [[Dihydrotestosterone co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; bisphenol A inhibits the reaction [[Estradiol co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; Flutamide inhibits the reaction [[bisphenol A co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein] Glutamic Acid results in increased phosphorylation of MAPK1 protein 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [[JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; [3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein; [cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein; [JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein; AM 251 inhibits the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; AM 251 inhibits the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; AM 251 inhibits the reaction [[JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; CNR1 protein affects the reaction [Glutamic Acid results in increased phosphorylation of MAPK1 protein]; GRM5 protein affects the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; GRM5 protein affects the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; GRM5 protein affects the reaction [[JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of MAPK1 protein]; GRM5 protein affects the reaction [Glutamic Acid results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:27543109 PMID:30707916 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions increases phosphorylation
|
EXP ISO
|
[bisphenol A co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein; [Dihydrotestosterone co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein; [Estradiol co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein; afimoxifene inhibits the reaction [[bisphenol A co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; bisphenol A inhibits the reaction [[Dihydrotestosterone co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; bisphenol A inhibits the reaction [[Estradiol co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; Flutamide inhibits the reaction [[bisphenol A co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein] 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [[JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; [3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein; [cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein; [JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein; AM 251 inhibits the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; AM 251 inhibits the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; AM 251 inhibits the reaction [[JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; CNR1 protein affects the reaction [Glutamic Acid results in increased phosphorylation of MAPK3 protein]; GRM5 protein affects the reaction [[3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; GRM5 protein affects the reaction [[cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; GRM5 protein affects the reaction [[JZL 184 co-treated with Glutamic Acid] results in increased phosphorylation of MAPK3 protein]; GRM5 protein affects the reaction [Glutamic Acid results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:27543109 PMID:30707916 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions increases phosphorylation
|
EXP
|
shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of MAPK8 protein]
|
CTD |
PMID:35028790 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
increases phosphorylation multiple interactions
|
EXP
|
Glutamic Acid results in increased phosphorylation of MAPK9 protein shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of MAPK9 protein]
|
CTD |
PMID:35028790 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Nckap1
|
NCK-associated protein 1
|
decreases expression
|
EXP
|
Glutamic Acid results in decreased expression of NCKAP1 mRNA
|
CTD |
PMID:25797319 |
|
NCBI chr 3:85,824,333...85,898,748
Ensembl chr 3:85,824,336...85,898,797
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
affects localization multiple interactions
|
ISO
|
Glutamic Acid affects the localization of NFE2L2 protein gastrodin affects the reaction [Glutamic Acid affects the localization of NFE2L2 protein] [dihydroactinidiolide co-treated with Glutamic Acid] results in increased expression of NFE2L2 mRNA
|
CTD |
PMID:31698019 PMID:33617922 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Palld
|
palladin, cytoskeletal associated protein
|
increases expression
|
EXP
|
Glutamic Acid results in increased expression of PALLD mRNA
|
CTD |
PMID:25797319 |
|
NCBI chr16:33,238,943...33,632,236
Ensembl chr16:33,238,956...33,632,232
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
multiple interactions
|
ISO
|
[Glutamic Acid co-treated with asiatic acid] results in increased expression of PPARGC1A protein
|
CTD |
PMID:22447225 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Ppia
|
peptidylprolyl isomerase A
|
decreases expression
|
EXP
|
Glutamic Acid results in decreased expression of PPIA mRNA
|
CTD |
PMID:25797319 |
|
NCBI chr14:85,491,223...85,496,884
Ensembl chr14:85,492,484...85,497,115
|
|
| G
|
Prdx6
|
peroxiredoxin 6
|
decreases expression
|
ISO
|
Glutamic Acid results in decreased expression of PRDX6 mRNA; Glutamic Acid results in decreased expression of PRDX6 protein
|
CTD |
PMID:26447207 |
|
NCBI chr13:76,062,082...76,072,631
Ensembl chr13:76,061,554...76,072,657
|
|
| G
|
Psen1
|
presenilin 1
|
multiple interactions
|
ISO
|
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Glutamic Acid; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Glutamic Acid]
|
CTD |
PMID:39172838 |
|
NCBI chr 6:109,054,160...109,106,191
Ensembl chr 6:109,060,352...109,106,189
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression multiple interactions
|
ISO
|
Glutamic Acid results in increased expression of PTGS2 mRNA; Glutamic Acid results in increased expression of PTGS2 protein gastrodin inhibits the reaction [Glutamic Acid results in increased expression of PTGS2 mRNA]; gastrodin inhibits the reaction [Glutamic Acid results in increased expression of PTGS2 protein]
|
CTD |
PMID:31698019 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Slc3a2
|
solute carrier family 3 member 2
|
multiple interactions increases expression
|
EXP
|
geissoschizine methylether promotes the reaction [Glutamic Acid results in increased expression of SLC3A2 mRNA]; hirsuteine promotes the reaction [Glutamic Acid results in increased expression of SLC3A2 mRNA]; hirsutine promotes the reaction [Glutamic Acid results in increased expression of SLC3A2 mRNA]; procyanidin B1 promotes the reaction [Glutamic Acid results in increased expression of SLC3A2 mRNA]; Yi-Gan San promotes the reaction [Glutamic Acid results in increased expression of SLC3A2 mRNA]
|
CTD |
PMID:25551766 |
|
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064
|
|
| G
|
Slc40a1
|
solute carrier family 40 member 1
|
multiple interactions decreases expression
|
ISO
|
gastrodin inhibits the reaction [Glutamic Acid results in decreased expression of SLC40A1 protein]
|
CTD |
PMID:31698019 |
|
NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:55,525,532...55,543,460
|
|
| G
|
Slc7a11
|
solute carrier family 7 member 11
|
increases expression multiple interactions
|
EXP
|
Glutamic Acid results in increased expression of SLC7A11 mRNA geissoschizine methylether promotes the reaction [Glutamic Acid results in increased expression of SLC7A11 mRNA]; hirsuteine promotes the reaction [Glutamic Acid results in increased expression of SLC7A11 mRNA]; hirsutine promotes the reaction [Glutamic Acid results in increased expression of SLC7A11 mRNA]; procyanidin B1 promotes the reaction [Glutamic Acid results in increased expression of SLC7A11 mRNA]; Yi-Gan San promotes the reaction [Glutamic Acid results in increased expression of SLC7A11 mRNA]
|
CTD |
PMID:25551766 |
|
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
|
|
| G
|
Snca
|
synuclein alpha
|
multiple interactions
|
EXP
|
Glutamic Acid inhibits the reaction [zolmitriptan inhibits the reaction [Reserpine results in increased expression of SNCA protein]]
|
CTD |
PMID:38229316 |
|
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:91,026,474...91,126,315
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression
|
ISO EXP
|
[TNF protein co-treated with Glutamic Acid] results in increased activity of MAP3K7 protein sinapinic acid inhibits the reaction [Glutamic Acid results in increased expression of TNF protein]
|
CTD |
PMID:36912451 PMID:39615638 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Trpm4
|
transient receptor potential cation channel, subfamily M, member 4
|
multiple interactions increases activity
|
ISO
|
9-phenanthrol inhibits the reaction [Glutamic Acid results in increased activity of TRPM4 protein] 9-phenanthrol inhibits the reaction [Glutamic Acid results in increased activity of TRPM4 protein]; YWHAG protein affects the reaction [Glutamic Acid results in increased activity of TRPM4 protein]
|
CTD |
PMID:25047048 |
|
NCBI chr 1:104,918,462...104,949,453
Ensembl chr 1:104,918,462...104,948,653
|
|
| G
|
Vdac1
|
voltage-dependent anion channel 1
|
increases expression
|
EXP
|
Glutamic Acid results in increased expression of VDAC1 mRNA
|
CTD |
PMID:25797319 |
|
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:37,023,145...37,060,541
|
|
| G
|
Xbp1
|
X-box binding protein 1
|
multiple interactions increases expression
|
EXP
|
MKC8866 promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of XBP1 protein alternative form]]; shikonin inhibits the reaction [Glutamic Acid results in increased expression of XBP1 protein alternative form]
|
CTD |
PMID:35028790 |
|
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
|
|
| G
|
Ywhag
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
|
multiple interactions
|
ISO
|
YWHAG protein affects the reaction [Glutamic Acid results in increased activity of TRPM4 protein]
|
CTD |
PMID:25047048 |
|
NCBI chr12:26,381,106...26,409,466
Ensembl chr12:26,380,816...26,409,465
|
|